Grape Seed Extract The Anti-Aging Nutrient

by | Jun 2, 2009


A green chalkboard with the message 'I LOVE YOU' written in white chalk.How would you like to look and feel 30 when you’re 50? Ponce de Leon should have looked in the vineyards of his own back yard for the “Fountain of Youth.” The secret was there all the time, hidden within the tiny seeds of Europe’s finest vineyard grapes. The key ingredient is a substance extracted from the seeds and skins of grapes; a polyphenol bioflavonoid known as Proanthocyanidin and abbreviated OPC for short.


Dr. Hansen has put this powerful bioflavonoid into a capsule and bottled it in what he calls “the most potent preventive medicine you can take.” Dr. Hansen has put this pharmaceutical grade Grape Seed Extract into GSE Ultra 110, Flavinox and Joint Repair. This remarkable natural supplement may be the most important medical discovery of the century. Wrinkles, age spots, varicose veins, and cellulite are much more than mere vanity diseases. They are signs of a systemic deficiency of these essential bioflavonoids which protect and promote collagen synthesis. GSE Ultra 110 will help you look and feel younger and more vibrant by improving the suppleness of your skin, and delaying or reducing the appearance of wrinkles, varicose veins, cellulite, scars, easy bruising, edema, and age spots.


A deficiency of OPC bioflavonoids leads to aging and damaged collagen and elastin throughout the body, including the skin, joints, and blood vessels and may be a cause of heart disease, cancer, strokes, diabetes, arthritis, and Alzheimer’s disease.


You Are Only As Young As Your Connective Tissue

A green chalkboard with the message 'I LOVE YOU' written in white chalk.To a large extent, youthfulness is determined by the suppleness of your collagen and elastin. The skin, the blood vessels, the joints and every membrane within the body are laced together with these connective tissue components.


During infancy, the connective tissue is extremely soft and pliable. Over time the collagen and elastin fibers gradually become cross-linked by free radical damage. As this happens, your skin becomes leathery and wrinkled. Your arteries lose their elasticity and become hardened. Your joints and cartilage stiffen. The lens of your eye becomes cross-linked and clouded. Your spine becomes stiff and bent. Even the neurons of your brain become entangled and damaged. In short every part of your body gradually deteriorates.


The good news is you GSE Ultra 110 can prevent free-radical damage to collagen and elastin, push back the clock, and reverse the effects of aging on your body. GSE Ultra 110 is a super-antioxidant providing 50 times more antioxidant protection than Vitamin E and 20 times more protection than Vitamin C.


A green chalkboard with the message 'I LOVE YOU' written in white chalk.When taken orally, GSE Ultra 110 is rapidly absorbed into the blood stream and distributed to the connective tissue where it fights free radical damage, inhibits collagen destroying enzymes, promotes new collagen and elastin formation and slows or even reverses the biological process of aging.


By protecting, restoring and strengthening the collagen and elastin fibers throughout the body, GSE Ultra 110 can reduce the unsightly appearance of varicose veins, the tendency to easy bruising, swelling of the legs, aching pains and stiffness of the joints and hardening of the arteries.


GSE Ultra 110 is the most potent preventive medicine that you can take. If you want to reverse the aging process and look and feel young again, you need to try this product.


Success Stories

Beverly J., Dallas,TX

I have been taking the GSE Ultra 110 for two months now. The brown spots on my skin are clearing up. The arthritic lumps on my fingers have gone down, and my gums are more firm. The dentist was concerned at the pockets around my back teeth and was amazed at my last visit when this condition had disappeared. I feel wonderful.


Darlene H., Dallas,TX

After seven days on GSE Ultra 110 I had no more pain or discomfort in my arthritic thumbs, no more discomfort in my knees when I went upstairs, and more energy than I thought possible. My varicose veins are even going away, the brown spots on the back of my hands are disappearing, the nightly itching of the skin on my back has completely gone away, and my legs are very seldom restless at night anymore.


Christine P., Los Angeles, CA

I used to be embarrassed to wear a two-piece bathing suit because of a surgical scar on my abdomen. But since I’ve been taking GSE Ultra 110, over the past two months the scar has shrunk and now is only faintly visible.


Peggy G., Scottsdale, AZ

I was already feeling good when I started taking GSE Ultra 110. I was taking it for its preventive benefits. However, to my surprise, within a few weeks everyone at my work was asking me what I was using on my skin because it looked younger and healthier.


Cheryl S., Salinas, CA

I consider GSE Ultra 110 a gift from the heavens. Before taking grape seed extract, I just thought my aches and pains were just part of getting older. I’m 51 years old and all my joints had gotten stiff. Within one month of starting GSE Ultra 110 I started to limber up. I lost a lot of the pain in my neck and upper back and to my surprise many of the age spots on my skin went away, I lost a lot of the sagging of my skin and I have fewer spider veins. I feel so much more alive and have more energy.

Ivermectin + Mebendazole taken together produce remarkably Positive Clinical Cancer Benefits in 84.4% of Patients.

The largest real-world human analysis to date evaluating ivermectin and mebendazole in cancer patients has just been published—and the results represent one of the most compelling clinical signals ever documented for repurposed anti-parasitic therapies in oncology.

This groundbreaking analysis was made possible through a unique collaboration between The Wellness Company, the McCullough Foundation, and the Chairman of the President’s Cancer Panel (Dr. Harvey Risch)—uniting real-world clinical data, frontline medical experience, and high-level epidemiologic expertise to deliver urgently needed insights in oncology.

This was a real-world prospective clinical program evaluation of 197 cancer patients, with 122 completing a follow-up survey at about six months (61.9% response rate).

Cancer patients were prescribed compounded ivermectin–mebendazole, with each capsule containing 25 mg ivermectin and 250 mg mebendazole—most commonly taken at 1–2 capsules per day.

The cohort represented a clinically relevant population, including a wide variety cancer types, with 37.1% of patients reporting actively progressing disease at baseline and many having already undergone chemotherapy, radiation, and surgery.

At six months, 84.4% of cancer patients reported clinical benefit (Clinical Benefit Ratio: 84.4% [95% CI: 77.0–89.8%]):

✅ 32.8% reported NO evidence of cancer (95% CI: 25.1–41.5%)
✅ 15.6% reported tumor regression (95% CI: 10.2–23.0%)
✅ 36.1% reported stable disease (95% CI: 28.1–44.9%)

Treatment adherence was high, with 86.9% completing the full protocol and 66.4% remaining on therapy at six months.

The regimen was well tolerated, with 25.4% reporting side effects, primarily mild and gastrointestinal, and over 93% continuing treatment despite these events.

Patients were treated in real-world conditions alongside concurrent therapies, including chemotherapy (27.9%), radiation (21.3%), surgery (19.7%), supplements (49.2%), and dietary modification (37.7%), supporting use as an adjunctive approach.

Together, these findings represent a large, internally consistent real-world clinical signal that supports URGENT further investigation of ivermectin and mebendazole as low-toxicity, adjunctive cancer therapies.

Given the strength of the signal observed here, advancing this line of investigation is no longer optional—it is necessary.

This is NOT the end. We will continue advancing this work with larger datasets to further define and validate the role of anti-parasitics in cancer outcomes.

The manuscript is now available as a preprint on the Zenodo research repository, operated by the European Organization for Nuclear Research, while undergoing peer review at leading oncology journals: “Real-World Clinical Outcomes of Ivermectin and Mebendazole in Cancer Patients: Results from a Prospective Observational Cohort.”

Bar chart showing distribution of common cancer types with breast cancer most prevalent.
Infographic on disease status and median duration since diagnosis.

Receive Our Newsletter

6 + 13 =

jQuery( document ).ready(function( $ ) { // $( "div" ).hide(); });